Capillary Leak Syndrome Induced by Recombinant Human Interleukin-11

Shen Jianjun,Hu Zhigang,Zhang Hongyan

DOI: https://doi.org/10.3760/cma.j.issn.1008-5734.2018.01.019

2018-01-01

Abstract:A 49-year-old male patient with recurrent nasopharyngeal carcinoma with multiple metastasis showed platelet count of 52 ×109/L on the second day after the end of the second cycle of chemotherapy. Recombinant human interleukin-11 was given 1.5 mg once daily by hypodermic injection. Four days later,the patient presented with systemic edema,hypoproteinemia,hydrothorax,peritoneal effusion and hypoproteinemia(total protein 57 g/L,albumin 33 g/L). Blood pressure declined to 95/67 mmHg(1 mmHg=0.133 kPa). The capillary leak syndrome was diagnosed. It was considered to be related to recombinant human interleukin-11. Interleukin-11 was stopped,5 g of human serum albumin and 10 mg of dexamethasone were given intravenously once a day,and 0.15 g of asecuven forte was given orally twice a day. Meanwhile,best support therapy was given. Six days later,the edema disappeared and all the parameters gradually returned to normal.